Mdma molecule:

Image from PubChem

Mdma Clinical Trials

An Open-Label, Phase 2, Feasibility Study of Manualized MDMA-Assisted Psychotherapy in Subjects with Major Depressive Disorder

To see complete record on, please visit this link

Id: 2021-000805-26

Organisation Name: Østfold Hospital Trust

Start Date: 2021-11-19

Completion Date: Ongoing

Brief Summary: The primary objective is to evaluate the effect of MDMA-assisted psychotherapy for MDD in clinician-rated depression scores, as measured by the mean change in MADRS scores from Visit 4 (Baseline) to Visit 13 (approximately 12 weeks post Baseline). The 10-item MADRS measures severity of depression and each item is rated on a 7-point scale from 0 (no symptoms) to 6 (severe symptoms)

Country: Norway

Total execution time in seconds: 0.091276168823242